Gsa Capital Partners LLP Vanda Pharmaceuticals Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 30,423 shares of VNDA stock, worth $134,165. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,423Holding current value
$134,165% of portfolio
0.01%Shares
17 transactions
Others Institutions Holding VNDA
# of Institutions
157Shares Held
44.9MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$35.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$17.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$16 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$9.97 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $249M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...